Hightower Advisors LLC Maintains Stake in Abbott Labs (ABT)

Marco Green
April 23, 2018

BlackRock Inc. now owns 110,201,384 shares of the healthcare product maker's stock valued at $6,289,191,000 after purchasing an additional 3,566,731 shares during the period. Zions Bancorporation boosted its position in shares of Abbott Laboratories by 0.4% in the fourth quarter. Carlson Capital Management who had been investing in Abbott Labs for a number of months, seems to be bullish on the $103.37 billion market cap company.

The stock decreased 1.15% or $0.69 during the last trading session, reaching $59.19. About 4.33M shares traded. Since April 22, 2017 ABT has risen 34.85% and is uptrending. It has outperformed by 23.30% the S&P500.

Check Capital Management Inc decreased its stake in Aflac (AFL) by 79.15% based on its latest 2017Q4 regulatory filing with the SEC. Rikoon Group LLC raised its position in shares of Abbott Laboratories by 0.4% during the second quarter.

Tiverton Asset Management Llc increased Abbott Laboratories (ABT) stake by 3.39% reported in 2017Q4 SEC filing. The stock increased 0.55% or $0.21 during the last trading session, reaching $38.05. Waldron LP has 7,347 shares. Scripps Networks Interactive, Inc. It is down 0.00% since April 22, 2017 and is. It has underperformed by 11.55% the S&P500.

The Hightower Advisors Llc's stake in Stepan Co (NYSE:SCL) was upped by 340,834 shares to 399,834 shares valued at $31.58 million in 2017Q4, according to the filing. For a total of 642,398 shares it increased its holding in Tcg Bdc Inc by 506,394 shares in the quarter, and has risen its stake in Blackrock Inc (NYSE:BLK). Teacher Retirement System Of Texas invested in 0.36% or 943,587 shares. Therefore 72% are positive. Abbott Laboratories has a fifty-two week low of $42.88 and a fifty-two week high of $64.60. The stock has "Buy" rating by Cowen & Co on Wednesday, October 18. The firm has "Buy" rating by Jefferies given on Wednesday, October 18. BMO Capital Markets raised their price objective on Abbott Laboratories from $65.00 to $70.00 and gave the stock an "outperform" rating in a research report on Thursday, January 25th. The company was upgraded on Tuesday, January 2 by Morgan Stanley. The rating was maintained by Barclays Capital with "Overweight" on Thursday, January 25. The firm has "Buy" rating by Gabelli given on Friday, July 21. The rating was downgraded by Citigroup to "Sell" on Tuesday, September 26.

Investors of record on Friday, April 13th will be given a dividend of $0.28 per share. Its up 0.23, from 1.21 in 2017Q3.

A number of other institutional investors have also recently bought and sold shares of the business. Old Mutual Customised Solutions (Proprietary) has invested 0.15% in Abbott Laboratories (NYSE:ABT). JP Morgan maintained it with "Overweight" rating and $69 target in Thursday, January 25 report. Mycio Wealth Ptnrs Limited Liability stated it has 0.06% of its portfolio in Abbott Laboratories (NYSE:ABT). Capital Research Global Investors now owns 47,589,663 shares of the healthcare product maker's stock valued at $2,313,334,000 after purchasing an additional 14,918,038 shares during the period.

Shares of Abbott Laboratories (NYSE:ABT) opened at 43.68 on Wednesday. Profund Advisors Limited Liability holds 63,051 shs. The healthcare product maker reported $0.48 earnings per share for the quarter, beating analysts' consensus estimates of $0.43 by $0.05. New York-based Cannell Peter B Co has invested 2.02% in Abbott Laboratories (NYSE:ABT). Ifc Holding Incorporated Fl holds 20,219 shares. The institutional investor held 282,445 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $16.12 million, down from 319,574 at the end of the previous reported quarter. Gillespie Robinson & Grimm Incorporated invested in 13,424 shares. Strs Ohio, a Ohio-based fund reported 1.31 million shares.

Since October 23, 2017, it had 1 insider buy, and 18 insider sales for $23.52 million activity. Also, SVP Jared Watkin sold 996 shares of Abbott Laboratories stock in a transaction on Thursday, March 1st. 56,401 Abbott Laboratories (NYSE:ABT) shares with value of $3.36 million were sold by Fussell Stephen R. MANNING JOSEPH J sold $84,344 worth of stock.

In related news, insider Brian J. Blaser sold 27,733 shares of Abbott Laboratories stock in a transaction on Wednesday, January 31st. Contreras Jaime had sold 6,284 shares worth $375,381. Equities research analysts predict that Abbott Laboratories will post $2.47 EPS for the current year. Therefore 19% are positive. The company was maintained on Tuesday, January 9 by Wells Fargo. The company was maintained on Friday, September 1 by RBC Capital Markets. The firm has "Outperform" rating by RBC Capital Markets given on Friday, October 9. The firm has "Neutral" rating by BTIG Research given on Monday, January 22.

Several other research analysts have also commented on the company. The firm has "Hold" rating by RBC Capital Markets given on Tuesday, June 6. PiperJaffray upgraded the stock to "Neutral" rating in Monday, November 21 report. (NASDAQ:FOSL) earned "Hold" rating by Jefferies on Wednesday, February 14. The company has a market cap of $104,570.48, a P/E ratio of 23.68, a P/E/G ratio of 1.77 and a beta of 1.50.

Since March 1, 2018, it had 0 insider buys, and 4 selling transactions for $12.48 million activity. Shares for $518,450 were sold by BIRD ROGER. Pure Financial Advisors Inc. now owns 11,004 shares of the healthcare product maker's stock worth $489,000 after buying an additional 45 shares in the last quarter. Watkin Jared sold $17,609 worth of stock. It is down 0.00% since April 21, 2017 and is. Its up 0.22, from 0.58 in 2017Q3. 90,881 were accumulated by Marshall Wace Llp. (NASDAQ:FOSL) for 345,480 shares. Aqr Cap Lc reported 41,633 shares. Fayerweather Charles holds 2.86% or 34,259 shares. The SI to TAV HAVALIMALARI HOLDING AS UNSPONSOREED's float is 0.01%. Grimes Company holds 0.5% of its portfolio in Scripps Networks Interactive, Inc. The Manitoba - Canada-based Great West Life Assurance Can has invested 0.05% in Scripps Networks Interactive, Inc. Virtus Advisers stated it has 4,949 shares. Carlson Capital Management bought 55,173 shares as the company's stock rose 5.88% while stock markets declined. Wall Street Access Asset Mngmt Ltd Liability reported 0.58% stake.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER